臺灣博碩士論文加值系統

樟芝（Antrodia camphorata）為台灣特有種真菌，因只生長在台灣特有的牛樟樹中，數量稀少而珍貴，民間長久以來皆視為治療肝臟疾病之聖品。而肝炎及肝硬化等肝臟疾病久為十大死因之一，長期威脅著國人的健康，故開發治療肝病的藥物實為當務之急。本研究即以樟芝發酵液水萃後製成的樟芝水為材料，進行保肝功能成效的研究，期望能對國人健康有所貢獻。
實驗以Wistar大鼠為動物模式，隨機分為五組。A組：正常控制組（未經四氯化碳處理，其餘則皆經四氯化碳處理）。B組：負控制組（CCl4組）。C組：正對照組（Silymarin組）。D組：低劑量實驗組（樟芝水1X）。E組：高劑量實驗組（樟芝水5X）。實驗進行四週，結果顯示：在血清生化值方面，樟芝水實驗組（D、E組）的glutamyl oxaloacetic transaminase（GOT）和glutamyl pyrubic transaminase（GPT）與負控制組間的差異皆達到顯著水準（p < 0.05），且與正常控制組間沒有顯著差異，代表樟芝水可降低肝功能指數至與正常值接近。但兩組實驗組（樟芝水1X與樟芝水5X）間並無顯著差異，代表增加樟芝水劑量並無法增加功效。在triglyceride與cholesterol方面，樟芝水1X與5X兩組和負控制組間皆可達到顯著差異，表示樟芝水可有效降低血脂肪含量，但兩實驗組間的效果差異不顯著。在肝臟中的抗氧化效果部份，抗氧化物Glutathione（GSH）在所有各組間的含量均無顯著差異，但樟芝水可顯著提升抗氧化酵素superoxide dismutase（SOD）在肝臟中的活性，對於肝臟中catalase（CAT）的活性則略有提升效果，然而並未達到顯著水準。由以上結果可知，樟芝水對於四氯化碳所誘發的肝損傷具有保護功效，亦有降低血脂肪的效果。

Antrodia camphorata is a unique species of fungus that only growes on Cinnamomum kanehirai in Taiwan. It is recognized as traditional herb for its liver protective function in Taiwan aborigines. It has long been known that liver disease is one of the top ten killers in Taiwan. Therefore, it is important to develop medicine that curing liver diseases. The aim of this study was to investigate the hepatoprotective effect of liquid extractive Antrodia camphorate (LEAC), which is the water extract of solid form of Antrodia camphorata fermentation, and to see if the LEAC might help liver function.
The present study used Wistar rats as our study animal . Twenty rats were divided into five groups: Normal control (Background control no CCl4 was introduced), Negative control (CCl4 alone and feed only with solvent), Test group one [the CCl4+silymarin (positive drug control)], Test group two (CCl4+1X LEAC), and Test group three (CCl4+5X LEAC.)
Our results showed that the LEAC might have liver protective function as our data in test groups. Either 1X or 5X LEAC could reduce the liver damages that caused by CCl4. These results could be demonstrated by the significantly decreased serum levels of GOT and GPT after feeding 1X and 5X LEAC, LEAC can also reduce the content of triglyceride and cholesterol in serum. In addition, the antioxidant status in liver of rats were tested. The content of glutathione did not show significantly decrease among five groups, but feeding LEAC significantly restored the activities of antioxidant enzyme SOD. The activities of catalase rose after feeding LEAC, but the effect isn’t significant.

第一章　文獻回顧…………………………………………………………..………..1
　　第一節　樟芝簡介……………………………………………………..………..1
　　第二節　樟芝功效介紹………………………………………………..………..5
　　第三節　肝損傷模式探討……………………………………………..……….11
　　第四節　水飛薊素……………………………………………………..……….14
　　第五節　實驗動機……………………………………………………..……….16
第二章　實驗材料與方法…………………………………………………..……….17
　　第一節　實驗材料…………………………………………………….………..17
　　第二節　實驗方法…………………………………………………….………..18
第三章　結果……………………………………………………………….………..22
　　第一節　樟芝水對CCl4誘導肝損傷大鼠之體重變化……………..…………22
　　第二節　樟芝水對CCl4誘導肝損傷大鼠血清生化值的影響……………..…23
　　第三節　CCl4誘導肝損傷大鼠服用樟芝水後肝臟中的GSH含量變化……….26
　　第四節　CCl4誘導肝損傷大鼠服用樟芝水後肝臟中SOD及CAT含量變化……26
第四章　討論………………………………………………………………………...28
　　第一節　體重…………………………………………………………………...28
　　第二節　肝功能指數…………………………………………………………...28
　　第三節　血脂肪………………………………………………………………...30
　　第四節　抗氧化物與抗氧化酵素……………………………………………...31
第五章　結論……………………………………………………………...………...34
第六章　參考文獻…………………………………………………………………..44

江蘇新醫學院，中藥大辭典，下冊，上海科學技術出版社，1997
李一宏，樟芝菌絲體之培養及其多醣體抗乙型肝炎病毒活性評估，中國醫藥學院 中國藥學研究所博士論文，2003
李貞宜，樟芝保肝作用之探討，南台科技大學生物科技系碩士論文，2005
李炫璋，牛樟芝菌絲體之體內保肝功能評估及其熱水萃物在體外對基質金屬蛋白水解酶活性之影響，國立中興大學食品科學系碩士論文，2003
李國珍，水飛薊造福現代人，杏輝醫藥雜誌，第32期，2002
呂美津，牛樟菇子實體乙醇萃取物誘導HL60細胞凋亡之研究，屏東科技大學熱帶農業暨國際合作研究所碩士論文，2003
宋祖瑩，樟芝深層培養液抗氧化及抗腫瘤特性之研究，國立中興大學食品科學系碩士論文，2003
吳昇原，牛樟抽出物對樟芝生長影響之探討，國立台灣大學森林學研究所碩士論文，2002
吳德鵬，樟芝微量成分之研究，國家台灣師範大學化學研究所碩士論文，1995。
范真綺，樟芝固態栽培與液態發酵菌絲體之成分及其生物活性之研究，南台科技大學化學工程系碩士論文，2004
高郁婷，牛樟抽出物及精油對樟芝菌絲及子實體生長之影響，國立台灣大學森林學研究所碩士論文，2003
高曉薇，臺灣靈芝屬新種樟芝之三帖類成分研究，台北醫學院天然物醫學研究所碩士論文，1992
許勝傑、陳清農、陳勁初，樟芝宿主專一性之探討，台灣農業化學與食品科學，38: 533-539，2000
曹巧吟，樟芝中免疫調節蛋白的純化與其生理活性之探討，國立臺灣大學園藝學研究所碩士論文，2003
陳心慧，牛樟芝不同極性區分保肝機能性之研究，中山醫學大學營養科學研究所碩士論文，2004
陳伯珠，一.高通量篩選出牛樟芝菌絲體抗肝癌先導藥物化合物 二.以p53、bax、bcl-2 之m-RNA層次進行抗肝癌先導藥物化合物對人類肝癌細胞株HepG2凋亡途徑之探討，國立中正大學化學研究所碩士論文，2004
陳怡欣，牛樟芝發酵過濾液對大白鼠肝臟生理機能之影響，中國醫藥學院營養研究所碩士論文，2002
陳洳君，靈芝、樟芝、椎茸、桑黃萃取物在調節免疫反應及抗B型肝炎病毒能力之研究，實踐大學食品營養研究所，2005
陳啟楨，菇菇的世界，偉銘圖書股份有限公司，2004
陳嬿如，仙草對tert-butyl hydroperoxide誘發大鼠急性肝損傷與人類肝癌細胞(HepG2)氧化傷害之保護效果，國立中興大學食品科學系碩士論文，2003
張怡婷，樟芝抗腫瘤活性之研究，國立成功大學藥理學研究所碩士論文，2004
游明謙、李誌雄、賴呈委、江宜平、王櫻諭、許清祥，保肝中藥抽取物對半乳糖胺誘發急性肝細胞損傷之療效評估，J Chin Med 14(2): 99-108，2003
黃鈴娟，樟芝與姬松茸之抗氧化性質及其多醣組成分析，國立中興大學食品科學系碩士論文，2000
楊書威，中藥樟菇活性成分之研究，國立台灣大學藥學研究所碩士論文，1991
葉怡真，樟芝對血管內皮細胞之影響及保心血管疾病之機制探討，中國醫藥學院營養研究所碩士論文，2002
劉俊仁，中草藥抗癌機制研究:(壹):黃芩素及黃芩苷對血管新生作用之影響及其機制探討;(貳):樟芝活性多醣體之生物活性分析及其經由免疫調節抑制腫瘤生長之研究，國立臺灣大學生物化學暨分子生物學研究所博士論文，2003
劉翠玲，樟芝對倉鼠體內脂質代謝與抗氧化狀態之影響，輔仁大學食品營養學系碩士論文，2002
廖俊旺、蔡三福、王順成，四氯化碳對大鼠之毒性，組織病理研討會專輯，1996
蔡育真，固態發酵樟芝對小鼠免疫調節及抗腫瘤，南台科技大學生物科技系碩士論文，2004
蔡雁暉，樟芝深層培養液及其多醣體之抗氧化特性，國立中興大學食品科學系碩士論文，2002
盧祉彤，牛樟芝菌絲體對腫瘤細胞的影響，南台科技大學生物科技系碩士論文，2004
賴鈺菁，樟芝發酵液之抗發炎及其誘導癌細胞凋亡機制之探討，中國醫藥大學營養研究所碩士論文，2004
戴宇昀，樟芝菌絲體與子實體對四氯化碳及酒精誘導之慢性及急性肝損傷之保肝功能評估，國立中興大學食品科學系碩士論文，2001
魏佳瑜，固體栽培樟芝甲醇萃取物抗變異自由基功效與抗血小板凝集作用探討，臺北醫學大學公共衛生學系碩士論文，2003
簡淑娟，人工固體栽培樟芝成分抽離暨自由基清除抗變異活性探討，臺北醫學大學公共衛生學系碩士論文，2005
蘇慶華，健康的守護神【國寶樟芝】，愛克思文化事業有限公司，2002
嚴貴榮，樟芝對STZ誘發高血糖鼠血糖調節與抗氧化之影響，輔仁大學食品營養學系碩士論文，2002

Aebi H. Catalase in vitro. Methods in Enzymol. 105: 121-126. 1984
Brent JA., Rumack BH. Role of free radicals in toxic hepatic injury II.Are free radicals the cause of toxin-induced liver injury? J. Clin. Toxicol. 31: 173-196. 1993
Brown GD., Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 413: 36-37. 2001
Chang TT., Chou WN. Antrodia camphorata sp.Cinnmomum Kamehirai in Taiwan. Mycol. Res. 99: 756-758. 1995
Cheng J., Rajesh A., Junxuan L. Anti-Angiogenic Potential of a Cancer Chemopreventive Flavonoid Antioxidant, Silymarin: Inhibition of Key Attributes of Vascular Endothelial Cells and Angiogenic Cytokine Secretion by Cancer Epithelial Cells. Biochemical and Biophysical Research Communications. 276: 371-378. 2000
Cherng IH., Chiang HC., Cheng MC., Wang Y. Three New triterpenoids from Antrodia camphorata .Journal of Natural products. 58(3): 365-371. 1995
Cherng IH., Wu DP., Chiang HC. Triterpenoids from Antrodia cinnamomea. Phytochemistry. 41(1): 263-7. 1996
Chiang HC., Wu DP., Cherng IH., Ueng CH. A sesquiterpene lactone,phenyl and biophenyl compounds from Antrodia camphorata. Phytochemistry. 39(3): 613-616. 1995
Chidambara-Murthy KN., Jayaprakasha GK., Singh RP. Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models. J Agric Food Chem. 50: 4791-4795
Debashis D., Philip WP., Peter CB., Christopher G., Alexander S., Raymond F.T., Thomas WW. Antioxidant properties of colchicine in acute carbon tetrachloride induced rat liver injury and its role in the resolution of established cirrhosis. Biochimica et Biophysica Acta. 1502: 351-362. 2000
Ferencikova R., Cervinkova Z., Drahota Z. Hepatotoxic effect of D-galactosamine and protective role of lipid emulsion. Physiol Res. 52(1): 73-78. 2003
Fernando AC., Enrique JSP., José MP., Cristián OF., Emilio ARG., Aldo DM., Roger C., Marcelo GR. Beneficial Effects of Silymarin on Estrogen-Induced Cholestasis in the Rat: A Study In Vivo and in Isolated Hepatocyte Couplets. Hepatology. 34(2): 329-339. 2001
Fernando AC., Enrique JSP, José MP, Emilio ARG., Aldo DM., Marcelo GR. Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat. Biochemical Pharmacology. 66: 355-364. 2003
Kang JS., Jeon YJ., Park SK., Yang KH., Kim HM. Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1b and prostaglandin E2 synthesis by silymarin. Biochemical Pharmacology. 67: 75-181. 2004
Harada N., Kodama N., Nanba H. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett. 192: 181-187. 2003
Hseu YC., Chang WC., Hseu YT., Lee CY., Yech YJ., Chen PC., Chen JY. Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes. Life Sci. 71(4): 469-482.Yang HL. 2002
Hseu YC., Yang HL., Lai YC., Lin JG., Chen GW., Chang YH. Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells. Nutr Cancer. 48(2): 189-197. 2004
Hsiao G., Lin YH., Lin CH.,Chou DS., Lin WC., Sheu JR. The protective effects of PMC against chronic carbon tetrachloride-induced hepatotoxicity in vivo. Biol pharm bull. 24: 1271-1276. 2001
Hsiao G., Shen MY., Lin KH., Lan MH., Wu LY., Chou DS., Lin CH., Su CH., Sheu JR. Antioxidative and hepatoprotective effects of Antrodia camphorata extract. J Agric Food Chem. 51(11): 3302-3308. 2003
James LP., Mayeux PR., Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos. 31(12): 1499-1506. 2003
Jia JD., Michael B., Cho JJ., Martin R., Stefano M., Gabriele B., Ernst OR., Detlef S. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen a1(I) and TIMP-1. Journal of Hepatology. 35: 392-398. 2001
Jiang Z., Ypu DY., Chen XC., Wu J. Monitoring of serum markers of fibrosis during CCl4-induced liver damage. Effects of antifibrotic agents. J Hepatol.16: 282-289. 1992.
Kadiiska MB., Gladen BC., Baird DD., Dikalova AE., Sohal RS., Hatch GE., Jones DP., Mason PP., Barrett JC. Biomarkers of oxidative stressstudy: Are plasma antioxidants markers of CCl4 poisoning? Free Radic. Biol. Med. 28: 828-845. 2000
Kataoka K., Muta T., Yamazak S., Takeshige K. Activation of macrophage by linear (1-3)-b-D-glucans. J. Biol. Chem. 277: 36825-36831. 2002
Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit. Rev.Toxicol. 23: 21-48. 1993
Kim SG., Nam SY., Chung HC., Hong SY., Jung KH. Enchanced effectiveness of dimethy 1-4, 4’-dimethoxy-5,6,5’,6’,-dimethylene dioxylbiphenyl -2,2’- dicarboxylate in combination with garlic oil against experimental hepatic injury in rats and mice. J. Pharm. Pharmacol. 47: 678-682. 1995
Krishnakantha TP. and Lokesh BR. Scavenging of superoxide anions by spice principles. Ind J Exp Biol. 30: 133-134. 1993
Kucera O., Cervinkova Z., Lotkova H., Krivakova P., Rousar T., Muzakova V., Hezova R., Kandar R., Rudolf E. Protective effect of S-adenosylmethionine against D-galactosamine-induced injury of rat hepatocytes in primary culture. Physiol Res. 2005 Dec 12; [Epub ahead of print]
Letteron P., Labbe G., Degott C. Mechanism of the protective effects of silymarin against carbon tetrachlorideinduced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol. 39: 2027-2034. 1990
Lowry OH., Rosebrough NJ., Farr AL., Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275. 1951
Marklund S., Marklund G. Involvement of the superoxide anion radical in the oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47: 469-474. 1974
Mizuno T., Hagiwara T., Nakamura T., Ito H., Shimura K., Sumiya T., Asakura A. Antitumor activity and some properties of water-soluble polysaccharides from “Himematsutake,” the fruiting body of Agaricus blazei murill. Agric. Biol. Chem. 54: 2889-2896. 1990
Muto S., Vetvicka V., Ross GD. CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J Clin Immunol. 13: 175-184. 1993
Oliveira CPMS., Lopasso FP., Laurindo FRM., Leitáo RMC., Laudanna AA. Protection Against Liver Ischemia-Reperfusion Injury in Rats by Silymarin or Verapamil. Transplantation Proceedings. 33: 3010-3014. 2001
Olson EJ., Standing JE., Griego-Happer N., Hoffman OA., Limper AH. Fungal b-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophage. Infect. Immun. 64: 3548-3554. 1996
Poon MKT., Chiu PY., Mark DHF., Ko KM. Metformin protects against carbon tetrachloride hepatoxicity in mice. J. Pharmacol. Sci. 93: 1-3. 2003
Reed DJ., Babson JR., Beatty PW., Brodie AE., Ellis WW., Potter DW. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Ana. Biochem. 106: 55-62. 1980
Sachan DS., Dodson WL. Effects of L-carnitine on carbon tetrachloride-induced changes in serum and liver lipids and acylcarnitines. J. Environ. Pathol. Oncol. 11(3): 125-129. 1992
Saller R., Meier R., Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 61: 2035-2063, 2001
Sheela CG., Angusti KT. Antiperoxide effects of S-allyl cystein sulphoxide isolated from Allium sativum Linn and gugulipid in cholesterol diet fed rats. Ind J Exp Biol. 33: 337-341. 1995
Sheikh AT., Kaiser P., Supriya K., Rinku B., Rakesh KJ. Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin. Hepatology Research. 31: 132-135. 2005
Slater TF., Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogeno-alkanes on peroxidative reactions in rat liver fractions in vitro. Biochem. J. 123: 805-814. 1971
Sohn JH., Han KL., Lee SH., Hwang JK. Protective Effects of Panduratin A against Oxidative Damage of tert-Butylhydroperoxide in Human HepG2 Cells. Biol. Pharm. Bull. 28(6): 1083-1086. 2005
Song TY., Yen GC. Antioxidant properties of Antrodia camphorata in submerged culture. J Agric Food Chem. 50(11): 3322-3327. 2002
Song TY., Yen GC. Protective effects of fermented filtrate from Antrodia camphorata in submerged culture against CCl4-induced hepatic toxicity in rats. J Agric Food Chem. 51(6): 1571-1577. 2003
Soto C., Mena R., Luna J., Cerbón M., Larrieta E., Vital P., Uría E., Sánchez M., Recoba R., Barrón H., Favari L., Lara A. Silymarin induces recovery of pancreatic function afteralloxan damage in rats. Life Sciences. 75: 2167-2180. 2004
Soto C., Recoba R., Barrón H., Alvarez C., Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetesin rat pancreas. Comparative Biochemistry and Physiology Part C. 136: 205-212. 2003
Sturgill MG., Lambert GH. Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin. Chem. 43: 1512-1526. 1997
Tanamly MD., Tadros F., Labeeb S., Makld H., Shehata M., Mikhail N.,Abdel-Hamid M., Shehata M., Abu-Baki L., Medhat A., Magder LS., Afdhal NH., Strickland GT. Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Digestive and Liver Disease. 36: 752-759. 2004
Turner WB., Aldridge DC. Fungus Metabolies II. 304-306. 1983
Vijayakumar M., Govindarajan R., Rao GMM., Rao CV., Shirwaikar A., Mehrotra S., Pushpangadan P. Action of Hygrophila auriculata against streptozotocin-induced oxidative stress. Journal of Ethnopharmacology. 104: 356-361. 2006
Wellington K., Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs. 15: 465-489. 2001
Wu SH., Yu ZH., Dai YC., Chen CT., Su CH., Chen LC., Hsu WC., Hwang GY. Taiwanofungus, a polypore new genus. Fung. Sci. 19: 109-116. 2004
Yang S.H., M.D., Lin JK., M.D.,Ph.D., Chen WS., M.D.,Ph.D., Chiu JH., M.D.,Ph.D. Anti-Angiogenic Effect of Silymarin on Colon Cancer LoVo Cell Line. Journal of Surgical Research. 113: 133-138.2003
Yang SW., Shen YC., Chen CH. Steroids and triterpenoids from Antrodia cinnamomea-a fungus parasitic on Cinnamomum micranthum. Phytochemistry. 41: 1389-1392. 1996
Yoshiji O., Emi S., Keiji N., Mutsumi K., Takahiro H., Minoru N., Isao I. Inhibitory effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on hepatic triglyceride accumulation with the progression of carbon tetrachloride-induced acute liver injury in rats. Journal of Ethnopharmacology. 61: 75-80. 1998